Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zhongfeng Huichun Pian is a traditional Chinese medicine (TCM) formula used primarily for the treatment and rehabilitation of stroke (cerebrovascular accident), especially for symptoms such as hemiplegia (paralysis on one side of the body), limb numbness, and partial paralysis. The formula is designed to promote blood circulation to remove blood stasis, relax muscles and tendons, and clear obstructions in the meridians. It is typically composed of a blend of herbs that may include ingredients like dong quai (Angelica sinensis), ginkgo biloba leaf extract, reishi mushroom (Ganoderma lucidum), among others; however, exact composition can vary by manufacturer. Zhongfeng Huichun Pian is widely used in China as an adjunct therapy for stroke recovery within TCM practice[1][2][5]. Its mechanism involves improving microcirculation and supporting neurological function post-stroke.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on zhongfeng huichun pian.